CRIS Current Research Information System

BRILLANTI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.131
EU - Europa 1.222
AS - Asia 606
AF - Africa 75
SA - Sud America 3
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.040
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.123
GB - Regno Unito 381
CN - Cina 244
SG - Singapore 203
SE - Svezia 188
DE - Germania 167
IT - Italia 167
IN - India 106
UA - Ucraina 69
IE - Irlanda 60
RU - Federazione Russa 56
FR - Francia 44
EE - Estonia 32
ZA - Sudafrica 30
VN - Vietnam 25
TG - Togo 21
BE - Belgio 17
CH - Svizzera 13
JO - Giordania 11
NG - Nigeria 11
BG - Bulgaria 10
CI - Costa d'Avorio 10
CA - Canada 7
IR - Iran 7
JP - Giappone 6
FI - Finlandia 4
GR - Grecia 4
NL - Olanda 4
SC - Seychelles 3
CZ - Repubblica Ceca 2
AT - Austria 1
AU - Australia 1
BR - Brasile 1
CL - Cile 1
ES - Italia 1
EU - Europa 1
ID - Indonesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
SI - Slovenia 1
SV - El Salvador 1
TR - Turchia 1
TW - Taiwan 1
Totale 4.040
Salva come PNG Salva come JPEG
Città #
Southend 348
Fairfield 274
Singapore 183
Chandler 167
Ashburn 150
Wilmington 134
Ann Arbor 121
Woodbridge 112
Houston 111
Santa Clara 102
Seattle 99
Boardman 82
Princeton 79
Cambridge 78
Dublin 59
Jacksonville 42
Nanjing 36
Westminster 34
Bologna 33
Padova 29
New York 26
Dong Ket 25
Saint Petersburg 22
Lomé 21
Medford 20
Beijing 17
Brussels 17
Bremen 16
Dearborn 16
San Diego 15
Shenyang 15
Berlin 14
Falls Church 12
Florence 12
Monmouth Junction 12
Abeokuta 11
Amman 11
Abidjan 10
Sofia 10
Tianjin 10
Guangzhou 9
Jinan 9
Mülheim 9
Redmond 9
Bern 8
Changsha 8
Milan 8
Redwood City 8
Dolo 7
Norwalk 7
Turin 7
Hebei 6
Jiaxing 6
Nanchang 6
Tokyo 6
Ardabil 5
Des Moines 5
Forlì 5
Fuzhou 5
Lake Forest 5
Siena 5
Washington 5
Wuhan 5
Chengdu 4
Haikou 4
Helsinki 4
Kunming 4
Moscow 4
Shanghai 4
Toronto 4
Buffalo 3
Casalecchio di Reno 3
Hangzhou 3
Imola 3
Leawood 3
Mahé 3
Ningbo 3
Phoenix 3
Suzhou 3
Taizhou 3
Xi'an 3
Aachen 2
Amsterdam 2
Andover 2
Bari 2
Bühl 2
Castrop-rauxel 2
Foshan 2
Kilburn 2
Lessolo 2
London 2
Mountain View 2
Qingdao 2
Radeberg 2
San Giovanni Lupatoto 2
Velletri 2
Venice 2
Asti 1
Athens 1
Auckland 1
Totale 2.834
Salva come PNG Salva come JPEG
Nome #
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 146
Reactivation of Crohn's disease after pandemic aH1N1 and seasonal flu vaccinations. 143
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 138
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes 131
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 130
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 130
Ribavirin for chronic hepatitis C: And the mystery goes on. 127
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice 127
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study 123
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients 120
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C. 120
Role of amantadine and other adjuvant therapies in the treatment of hepatitis C. 116
Terapia cellulare in Epatologia 115
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 115
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 114
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis 113
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 111
null 107
Direct antiviral therapy for hepatitis C and hepatocellular carcinoma: facing the conundrum 103
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3. 102
Severe acute autoimmune hepatitis after natalizumab treatment. 100
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 99
Proctosigmoidite ulcerosa refrattaria e recidivante alla terapia topica trattata con beclometasone dipropionato orale 96
null 96
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 96
Imaging Features of Microvascular Invasion in Hepatocellular Carcinoma Developed in HCV-Related Cirrhosis after Direct-Acting Antiviral Therapy. 91
Loss and seroconversion of hepatitis B surface antigen after vaccine therapy in chronic hepatitis B patients treated with nucleoside/nucleotide analogues. 88
Enhanced response to peginterferon-alpha-2a based triple therapy in previously non-responsive chronic hepatitis C: Final results of PRETTY study. 85
Trattamento della Epatite da HCV 82
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients 79
HEPATIC DECOMPENSATION RISK IS REDUCED, BUT NOT ELIMINATED AFTER DIRECT-ACTING ANTIVIRALS: THE ROLE OF SPLEEN STIFFNESS MEASUREMENT 78
RIBAVIRIN PRIMING ENHANCES EFFICACY OF CHRONIC HEPATITIS C RE-TREATMENT IN PATIENTS WHO HAD NOT RESPONDED TO PREVIOUS COMBINATION THERAPY 75
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 72
Prospective evaluation of aberrant p16 methylation in serum of patients before and after therapy for localized HCC. 71
null 70
VIROLOGICAL FAILURES TO NEW DIRECT ACTING ANTIVIRALS IN A REAL LIFE SETTING MAY REQUIRE UNCONVENTIONAL REGIMENS FOR RE-TREATMENT 70
La ribavirina nell'epatite cronica C: storia e segreti di un grande successo. 69
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals 66
A multimedia multilanguage web-based platform can assess and increase the awareness on HCV infection of Pakistani people living in Italy 66
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older 54
DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 50
Low recurrence rate of hepatocellular carcinoma after liver transplantation: Better patient selection or lower immunosuppression? 30
Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues-A Delphi Consensus Project 28
Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pyloni in dyspeptic patients 7
Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pyloni in dyspeptic patients 7
Totale 4.156
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.316
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.316
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020585 0 0 0 0 0 96 128 120 109 58 33 41
2020/2021468 97 44 21 16 20 18 10 28 56 47 29 82
2021/2022829 42 39 33 53 71 49 15 39 30 47 291 120
2022/2023741 76 85 42 111 61 66 16 41 125 17 60 41
2023/2024240 12 49 16 17 32 51 10 9 26 4 1 13
2024/2025550 41 160 89 59 160 41 0 0 0 0 0 0
Totale 4.156